CELYAD ONCOLOGY SA Depreciation Rightofuse Assets
CELYAD ONCOLOGY SA reported Depreciation Rightofuse Assets of EUR 528.00 thousand for the 6-month period ending 2020-06-30, per its 6-K filed 2020-08-07.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:DepreciationRightofuseAssets · last filed 2020-08-07
| Period end | Depreciation Rightofuse Assets 6 month | Depreciation Rightofuse Assets 12 month |
|---|---|---|
| 2020-06-30 | 528.00K EUR 6-K · filed 2020-08-07 | |
| 2019-12-31 | 1.04M EUR 20-F · filed 2020-03-25 | |
| 2019-06-30 | 522.00K EUR 6-K/A · filed 2019-09-05 |